Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > ONC

<< Previous

Bullboard Posts

Next >>

Comment by Conquistador1on May 23, 2022 6:29pm

233 Views

Post# 34702531

RE:RE:RE:RE:RE:RE:RE:RE:ONC

Hey Sherlock (Noteable), I posted that I recently bought a 1000 shares. Pay attention! Yes, that is true. I'm the proud temporary owner of 1000 shares.
Yes, I bought a lot of shares when Matt replaced Brad back in late 2016, or so. I have no interest in searching through my stock transactions for you. Guess what Sherlock an investor/speculator can SELL shares. Yes, I have done that quite a few times.
I won't be joining your cult.

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity